Browsing Category

24314 posts
Anycubic and Thingiverse Announce Exclusive Partnership to Expand Access to 3D Models

Anycubic and Thingiverse Announce Exclusive Partnership to Expand Access to 3D Models

SHENZHEN, China, Oct. 23, 2026 /PRNewswire/ — Anycubic, a global brand in…
CSTS ENTERPRISES ESTABLISHES GLOBAL HEADQUARTERS IN NEW YORK CITY, ADVANCING GLOBAL GROWTH STRATEGY IN THE RISING EXPERIENCE ECONOMY

CSTS ENTERPRISES ESTABLISHES GLOBAL HEADQUARTERS IN NEW YORK CITY, ADVANCING GLOBAL GROWTH STRATEGY IN THE RISING EXPERIENCE ECONOMY

NEW YORK, Oct. 23, 2026 /PRNewswire/ — CSTS Enterprises (‘CSTS’ or the…
GMIF2026 Exhibition Recap: Innovation Across the AI Memory & Storage Chain on Show

GMIF2026 Exhibition Recap: Innovation Across the AI Memory & Storage Chain on Show

SHENZHEN, China, Oct. 23, 2026 /PRNewswire/ — The 5th GMIF Innovation Summit (Global…

AMTD IDEA's Total Assets Exceeded US$2.6 Billion as of 2026 Half Year and Sets Forth Clear Growth Path in Global Hospitality

Revenue from contracts with customers grew by 32.1% to US$32.0 million Hospitality…

Vantage Enhances Its V-Card Premium Payment Experience for CFD Traders

V-Card combines everyday spending, applicable transaction fees and convenient card management. PORT…

Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer

–  At the recommended Phase 3 dose (RP3D) of 1.6 mg/kg, zoci…

Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.

Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung…

2026 ESMO LBA | Innovent Announces International Phase 3 Study of Arcotatug Tavatecan (CLDN18.2-ADC) in Gastric Cancer Met Dual Primary Endpoints of PFS and OS

Registrational Phase 3 G-HOPE-001 Study Met Both Primary Endpoints, Demonstrating Statistically Significant…